Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
32.76
-0.15 (-0.46%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $1 billion as of September 8, 2026. Its market cap has increased by 46.44% in one year.
Market Cap
1.00B
Enterprise Value
770.65M
1-Year Change
46.44%
Ranking
Category
Stock Price
$32.76
ChartMarket Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $1.00B, an increase of 713.32%. That is a compound annual growth rate of 34.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.00B | -11.86% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 3.59B |
| Veracyte | 3.42B |
| CareDx | 2.63B |
| GeneDx Holdings | 2.56B |
| NeoGenomics | 2.23B |
| Personalis | 1.84B |
| Freenome | 1.75B |
| OPKO Health | 1.22B |